About this trial
This study aims to test whether patients with Parkinson's disease can safely and effectively use a home-based exercise program guided by videos. Participants will follow video instructions for exercises at home while their movements are monitored by a camera, which provides real-time feedback. The study will check how well participants complete the exercises, their satisfaction with the program, and any changes in clinical function. The goal is to see if this type of home exercise can help patients increase their activity levels without significant side effects.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 19 years or older, clinically diagnosed with Idiopathic Parkinson's Disease (PD) according to the Movement Disorder Society (MDS) clinical diagnostic criteria
Patients at Hoehn and Yahr stage 1-2.5
Patients on stable dopaminergic therapy with no changes in the past 1 month
Patients receiving Lee Silverman Voice Treatment (LSVT) rehabilitation therapy once weekly as outpatients
Disqualifiers
Patients diagnosed with atypical parkinsonism
Patients with musculoskeletal problems that make participation in rehabilitation difficult
Patients who have limited access to the video-based home exercise feedback program
Trial design
Single group
Treatments tested in this trial
Home-based self-exercise feedback program using video
BehavioralParticipants follow a 6-week home-based exercise program using video-guided instructions and the iPixel exercise feedback system, which monitors movements in real-time and provides corrective feedback. The program includes: Stretching exercises, Strength training, Balance exercises, Aerobic exercises, LSVT-specific exercises. Participants are instructed to complete sessions at least 5 times per week, 40 minutes per session. Additionally, weekly 30-minute in-person rehabilitation sessions are conducted to adjust the next week's exercise intensity based on each participant's functional level.
Treatment groups
Trial outcomes
Primary outcomes
Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Part III (Motor Examination)
0 to 108, with higher scores indicating worse motor function.
Secondary outcomes
Modified Hoehn and Yahr sacle
Modified Hoehn and Yahr Scale Score range: 0 to 5, with higher scores indicating more severe disease stage.
Berg Balance Scale
0 to 56, with higher scores indicating better balance ability.
Functional Gait Ability
0 to 30, with higher scores indicating better gait function.
Freezing of Gait Questionnaire
0 to 24, with higher scores indicating more severe freezing of gait.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Seoul National University Hospital
Lead sponsor
Seoul National University Bundang Hospital
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: